Actinium Pharmaceuticals
ATNM
$9.53
Share price
-1.65%
Change (1 day)
6.48%
Change (1 year)
Categories
Actinium Pharmaceuticals (ATNM) Fails to deliver data
Key failure to deliver metrics for Actinium Pharmaceuticals:
- Last SEC data release: 2024-04-30
- Last 15 days FTD volume: $0.24 M
- Last 3 months FTD volume: $0.63 M
- Last year FTD volume: $2.53 M
Failures to deliver for Actinium Pharmaceuticals (ATNM) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Actinium Pharmaceuticals (ATNM) - since 2020
Volume in USD (price x number of shares), data since 2020Actinium Pharmaceuticals (ATNM) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.7 M | -80.97% |
| 2023 | $3.72 M | -55.7% |
| 2022 | $8.39 M | 15.29% |
| 2021 | $7.28 M | -18.57% |
| 2020 | $8.94 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Genocea Biosciences
GNCA | N/A | $0 M | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | $2.04 M | $4.98 M | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $1.77 M | $7.27 M | 🇺🇸 USA |